Cargando…

Full Antagonism of the Estrogen Receptor without a Prototypical Ligand Side Chain

Resistance to endocrine therapies remains a significant clinical problem for estrogen receptor-α (ERα)-positive breast cancer. On-target side effects limit therapeutic compliance and use for chemoprevention, highlighting an unmet need for new therapies. Here we present a full-antagonist ligand serie...

Descripción completa

Detalles Bibliográficos
Autores principales:	Srinivasan, Sathish, Nwachukwu, Jerome C., Bruno, Nelson E., Dharmarajan, Venkatasubramanian, Goswami, Devrishi, Kastrati, Irida, Novick, Scott, Nowak, Jason, Cavett, Valerie, Zhou, Hai-Bing, Boonmuen, Nittaya, Zhao, Yuechao, Min, Jian, Frasor, Jonna, Katzenellenbogen, Benita S., Griffin, Patrick R., Katzenellenbogen, John A., Nettles, Kendall W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5161551/ https://www.ncbi.nlm.nih.gov/pubmed/27870835 http://dx.doi.org/10.1038/nchembio.2236

Ejemplares similares

Ligand-binding dynamics rewire cellular signaling via Estrogen Receptor-α
por: Srinivasan, Sathish, et al.
Publicado: (2013)

OR12-07 Full Antagonism of Breast Cancer Cell Proliferation Can Result from Many Ligand-Induced Conformational Distortions of the Estrogen Receptor Ligand Binding Domain
por: Nwachukwu, Jerome, et al.
Publicado: (2020)

PHLDA1 Expression is Controlled by an Estrogen Receptor (ER)-NFκB-miR-181 Regulatory Loop and is Essential for Formation of ER+ Mammospheres
por: Kastrati, Irida, et al.
Publicado: (2014)

OR11-01 A New Model for Estrogen Receptor-alpha Antagonist Mechanism of Action
por: Nwachukwu, Jerome C, et al.
Publicado: (2023)

Resveratrol modulates the inflammatory response via an estrogen receptor-signal integration network
por: Nwachukwu, Jerome C, et al.
Publicado: (2014)

A novel aspirin prodrug inhibits NFκB activity and breast cancer stem cell properties
por: Kastrati, Irida, et al.
Publicado: (2015)

Estrogen receptor alpha somatic mutations Y537S and D538G confer breast cancer endocrine resistance by stabilizing the activating function-2 binding conformation
por: Fanning, Sean W, et al.
Publicado: (2016)

Estrogen receptor transcription and transactivation: Estrogen receptor alpha and estrogen receptor beta - regulation by selective estrogen receptor modulators and importance in breast cancer
por: S Katzenellenbogen, Benita, et al.
Publicado: (2000)

Identification of a novel ER-NFĸB-driven stem-like cell population associated with relapse of ER+ breast tumors
por: Semina, Svetlana E., et al.
Publicado: (2022)

Targeting the oncogenic transcription factor FOXM1 to improve outcomes in all subtypes of breast cancer
por: Katzenellenbogen, Benita S., et al.
Publicado: (2023)

Triaryl-Substituted Schiff Bases Are High-Affinity Subtype-Selective Ligands for the Estrogen Receptor
por: Liao, Zong-Quan, et al.
Publicado: (2014)

Tamoxifen down-regulation of miR-451 increases 14-3-3ζ and promotes breast cancer cell survival and endocrine resistance
por: Bergamaschi, Anna, et al.
Publicado: (2011)

Transcription Regulation and Genome Rewiring Governing Sensitivity and Resistance to FOXM1 Inhibition in Breast Cancer
por: Ziegler, Yvonne, et al.
Publicado: (2021)

The SERM/SERD bazedoxifene disrupts ESR1 helix 12 to overcome acquired hormone resistance in breast cancer cells
por: Fanning, Sean W, et al.
Publicado: (2018)

Predictive features of ligand‐specific signaling through the estrogen receptor
por: Nwachukwu, Jerome C, et al.
Publicado: (2016)

Integrative genomics of gene and metabolic regulation by estrogen receptors α and β, and their coregulators
por: Madak-Erdogan, Zeynep, et al.
Publicado: (2013)

Integrative genomics of gene and metabolic regulation by estrogen receptors α and β, and their coregulators
por: Madak‐Erdogan, Zeynep, et al.
Publicado: (2017)

Reversal of endocrine resistance in breast cancer: interrelationships among 14-3-3ζ, FOXM1, and a gene signature associated with mitosis
por: Bergamaschi, Anna, et al.
Publicado: (2011)

Macrophage-Elicited Loss of Estrogen Receptor Alpha in Breast Cancer Cells via Involvement of MAPK and c-Jun at the ESR1 Genomic Locus
por: Stossi, Fabio, et al.
Publicado: (2011)

Histone H3 binding to the PHD1 domain of histone demethylase KDM5A enables active site remodeling
por: Longbotham, James E., et al.
Publicado: (2019)

Structural mechanism for signal transduction in RXR nuclear receptor heterodimers
por: Kojetin, Douglas J., et al.
Publicado: (2015)

Pocket similarity identifies selective estrogen receptor modulators as microtubule modulators at the taxane site
por: Lo, Yu-Chen, et al.
Publicado: (2019)

Highly Sensitive Quantitative Imaging for Monitoring Single Cancer Cell Growth Kinetics and Drug Response
por: Mir, Mustafa, et al.
Publicado: (2014)

Suppression of Tumor Growth, Metastasis, and Signaling Pathways by Reducing FOXM1 Activity in Triple Negative Breast Cancer
por: Dey, Parama, et al.
Publicado: (2020)

Integration of Molecular Profiling and Chemical Imaging to Elucidate Fibroblast-Microenvironment Impact on Cancer Cell Phenotype and Endocrine Resistance in Breast Cancer
por: Holton, Sarah E., et al.
Publicado: (2014)

Transcriptomic analysis identifies gene networks regulated by estrogen receptor α (ERα) and ERβ that control distinct effects of different botanical estrogens
por: Gong, Ping, et al.
Publicado: (2014)

Pathway Preferential Estrogens Prevent Hepatosteatosis Due to Ovariectomy and High-Fat Diets
por: Zuo, Qianying, et al.
Publicado: (2021)

Coupling of Receptor Conformation and Ligand Orientation Determine Graded Activity
por: Bruning, John B., et al.
Publicado: (2010)

Telomerase Induction in HPV Infection and Oncogenesis
por: Katzenellenbogen, Rachel
Publicado: (2017)

Defining the Energetic Basis for a Conformational Switch Mediating Ligand-Independent Activation of Mutant Estrogen Receptors in Breast Cancer
por: Mayne, Christopher G., et al.
Publicado: (2021)

The therapeutic potential of RORγ modulators in the treatment of human disease
por: Chang, Mi Ra, et al.
Publicado: (2012)

Suppression of FOXM1 activities and breast cancer growth in vitro and in vivo by a new class of compounds
por: Ziegler, Yvonne, et al.
Publicado: (2019)

Respective role of membrane and nuclear estrogen receptor (ER) α in the mandible of growing mice: Implications for ERα modulation
por: Vinel, Alexia, et al.
Publicado: (2018)

The structural pervasiveness of estrogenic activity.
por: Katzenellenbogen, J A
Publicado: (1995)

PET Imaging Agents (FES, FFNP, and FDHT) for Estrogen, Androgen, and Progesterone Receptors to Improve Management of Breast and Prostate Cancers by Functional Imaging
por: Katzenellenbogen, John A.
Publicado: (2020)

Stringing along the estrogen receptor to engage with DNA
por: Katzenellenbogen, John A.
Publicado: (2023)

Highly Selective Salicylketoxime-Based Estrogen Receptor β Agonists Display Antiproliferative Activities in a Glioma Model
por: Paterni, Ilaria, et al.
Publicado: (2015)

FOXM1 regulates glycolysis and energy production in multiple myeloma
por: Cheng, Yan, et al.
Publicado: (2022)

THU480 Loss Of Selenof And A Western Diet Promote Mammary Tumorigenesis
por: Flowers, Brenna, et al.
Publicado: (2023)

The forkhead transcription factor FOXM1 promotes endocrine resistance and invasiveness in estrogen receptor-positive breast cancer by expansion of stem-like cancer cells
por: Bergamaschi, Anna, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_arhlosu3v85rgv30o467i8nhjm